ARTICLE | Clinical News
Cancer vaccine: Began Phase II testing
June 1, 1999 7:00 AM UTC
York Medical Inc., Mississauga, Ontario Product: Cancer vaccine Business: Cancer Therapeutic category: Immune stimulation Target: Epidermal growth factor (EGF) Description: Recombinant human epidermal...